Huntsman (HUN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
30 Jun, 2026Executive summary
Q2 2024 revenues were $1.57 billion, down 1% year-over-year, with net income attributable to Huntsman at $22 million and adjusted EBITDA at $131 million, reflecting lower selling prices but 9% higher sales volumes.
Diluted EPS was $0.13, adjusted diluted EPS $0.14; net income rose from $19 million in Q2 2023.
Operating cash flow from continuing operations was $55 million, up from $40 million in Q2 2023; free cash flow turned positive at $5 million.
The company completed the acquisition of SLIC joint venture assets and finalized the sale of its Textile Effects business.
Cost initiatives and cash discipline continue to support margin recovery and liquidity.
Financial highlights
Revenues decreased 1% year-over-year to $1.57 billion; adjusted EBITDA fell 16% to $131 million.
Net income attributable to Huntsman increased to $22 million; adjusted EBITDA margin for Q2 2024 was about 8%.
Free cash flow conversion improved to 26% from 4% year-over-year; net cash provided by operating activities was $55 million.
Net debt at June 30, 2024 was $1.58 billion, with liquidity of $1.3 billion.
Dividend per share increased to $0.25, a 5% rise year-over-year.
Outlook and guidance
3Q24 adjusted EBITDA expected between $115 million and $145 million; Polyurethanes $75–$90 million, Performance Products $35–$45 million, Advanced Materials $48–$53 million.
Full-year 2024 capital expenditures projected at $180–$200 million, with additional $15 million in pension/postretirement contributions.
Adjusted effective tax rate for 2024 expected at 30%–34%; long-term rate 22%–24%.
Management expects no substantial change in global economic activity through Q3 2024.
Focus remains on cost control, cash flow, and driving higher sales volumes and utilization rates.
Latest events from Huntsman
- Olin and Huntsman shareholders to vote on a merger of equals, forming OlinHuntsman Corporation.HUN
Proxy filing13 Jul 2026 - Q4 2024 saw revenue growth and improved EBITDA, but net loss and restructuring persist.HUN
Q4 20249 Jul 2026 - Revenue fell 5%, net loss narrowed, and a 65% dividend cut preserved cash amid restructuring.HUN
Q3 20258 Jul 2026 - $12B+ all-stock merger creates a chemicals leader with $400M+ synergies, closing H1 2027.HUN
M&A announcement16 Jun 2026 - $12B+ merger forms a chemicals leader with $400M+ synergies and balanced governance.HUN
Investor presentation16 Jun 2026 - Board elections, compensation, and auditor ratified; independent chair proposal rejected.HUN
AGM 202615 May 2026 - Net loss widened to $53M on flat revenue, with Advanced Materials outperforming other segments.HUN
Q1 20261 May 2026 - Board urges support for all director nominees, highlighting Mr. Muñoz’s strategic value despite attendance concerns.HUN
Proxy filing20 Apr 2026 - Annual meeting covers director elections, say-on-pay, auditor ratification, and governance proposal.HUN
Proxy Filing16 Mar 2026